Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
J Control Release. 2013 Dec 10;172(2):436-43. doi: 10.1016/j.jconrel.2013.05.034. Epub 2013 Jun 7.
The aim of this study was to investigate the effect of a specific and frequently used end group (lauryl alcohol) on the protein release and degradation kinetics of poly(DL-lactic-co-glycolic acid) particles of different sizes. Lauryl-capped PLGA and uncapped PLGA (referred to as PLGA-capped and PLGA-COOH, respectively) particles (0.3, 1 and 20 μm) were prepared by a double emulsion solvent evaporation technique. Bovine serum albumin (BSA) was used as a model protein for release studies. During degradation (PBS buffer, pH7.4 at 37°C), a slower dry mass loss was observed for 0.3 μm particles than for particles of 1 and 20 μm. It was further shown that PLGA-capped particles showed slower mass loss likely due to its more hydrophobic nature. It was found that the ester bond hydrolysis rate was substantially slower for PLGA-capped particles and that the rate increased with particle size. Particles showed enrichment in lactic acid content (and thus a decrease in glycolic acid content) in time, and interestingly PLGA-capped particles showed also an enrichment of the lauryl alcohol content. No difference was observed in degradation kinetics between BSA loaded and blank particles. Independent of size, PLGA-COOH based particles showed, after a small burst, a sustained and nearly complete release of BSA during 60-80 days. On the other hand, particles based on PLGA-capped showed a much slower release and exhibited incomplete release, accompanied by the presence of an insoluble residue remaining even after 180 days. FTIR analysis of this residue showed that it contained both polymer and protein. Considering the polymer enrichment in lauryl alcohol, the incomplete release observed for PLGA-capped is likely attributed to interactions between the protein and the lauryl end group. In conclusion, since PLGA-COOH, in contrast to the capped derivative, shows complete degradation as well as quantitative release of an entrapped protein, this polymer is preferred for the design of protein formulations.
本研究旨在探讨一种特定且常用的端基(月桂醇)对不同粒径聚(DL-丙交酯-共-乙交酯)颗粒的蛋白释放和降解动力学的影响。采用双乳液溶剂蒸发技术制备了月桂醇封端的 PLGA(简称 PLGA- capped)和无封端的 PLGA(简称 PLGA-COOH)颗粒(0.3、1 和 20μm)。牛血清白蛋白(BSA)被用作释放研究的模型蛋白。在降解过程中(PBS 缓冲液,37°C,pH7.4),与 1μm 和 20μm 颗粒相比,0.3μm 颗粒的干质量损失较慢。进一步表明,PLGA-capped 颗粒由于其疏水性更强,导致质量损失更慢。研究发现,PLGA-capped 颗粒的酯键水解速率明显较慢,且随粒径增大而增加。颗粒随时间推移显示出乳酸含量增加(即乙交酯含量减少)的富集现象,有趣的是,PLGA-capped 颗粒也显示出月桂醇含量的富集。载药和空白颗粒的降解动力学无差异。独立于粒径,PLGA-COOH 基颗粒在小爆发后,在 60-80 天内持续且几乎完全释放 BSA。另一方面,基于 PLGA-capped 的颗粒释放速度较慢,表现出不完全释放,并且在 180 天后仍存在不溶性残留物。对该残留物的傅里叶变换红外(FTIR)分析表明,其含有聚合物和蛋白质。考虑到聚合物中月桂醇的富集,PLGA-capped 观察到不完全释放可能归因于蛋白与月桂端基之间的相互作用。总之,由于 PLGA-COOH 与封端衍生物相比,显示出完全降解以及包封蛋白的定量释放,因此该聚合物更适合设计蛋白配方。